EyePoint Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
EyePoint Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q2 2024.
  • EyePoint Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 2, 2024 was 53.5M shares, a 53% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 53.5M +18.5M +53% Aug 2, 2024 10-Q 2024-08-08
Q1 2024 49.8M +15.5M +45.3% Mar 1, 2024 10-K 2024-03-08
Q3 2023 35.3M +1.23M +3.6% Oct 27, 2023 10-Q 2023-11-03
Q2 2023 35M +912K +2.68% Jul 28, 2023 10-Q 2023-08-04
Q1 2023 34.3M +258K +0.76% Apr 27, 2023 10-Q 2023-05-04
Q3 2022 34.1M +5.31M +18.5% Nov 1, 2022 10-Q 2022-11-04
Q2 2022 34.1M +5.3M +18.4% Aug 1, 2022 10-Q 2022-08-05
Q1 2022 34M +5.3M +18.5% Mar 4, 2022 10-K 2022-03-14
Q3 2021 28.8M -115M -80% Oct 29, 2021 10-Q 2021-11-05
Q2 2021 28.8M -96.4M -77% Jul 30, 2021 10-Q 2021-08-06
Q1 2021 28.7M -96M -77% Apr 26, 2021 10-K/A 2021-05-04
Q3 2020 144M +35.4M +32.7% Oct 30, 2020 10-Q 2020-11-06
Q2 2020 125M +18.9M +17.8% Jul 30, 2020 10-Q 2020-08-05
Q1 2020 125M +29.4M +30.8% Mar 5, 2020 10-K 2020-03-16
Q3 2019 108M +33.6M +45.1% Nov 4, 2019 10-Q 2019-11-07
Q2 2019 106M Aug 5, 2019 10-Q 2019-08-07
Q1 2019 95.4M +41.3M +76.5% Mar 13, 2019 10-KT 2019-03-18
Q3 2018 74.5M +35.1M +89.2% Sep 13, 2018 10-K 2018-09-18
Q1 2018 54M +14.8M +37.6% May 7, 2018 10-Q 2018-05-10
Q4 2017 45.3M +11.1M +32.4% Feb 5, 2018 10-Q 2018-02-08
Q3 2017 39.4M +5.2M +15.2% Sep 8, 2017 10-K 2017-09-13
Q1 2017 39.3M +5.1M +14.9% May 4, 2017 10-Q 2017-05-08
Q4 2016 34.2M +104K +0.31% Feb 3, 2017 10-Q 2017-02-09
Q3 2016 34.2M +4.76M +16.2% Sep 6, 2016 10-K 2016-09-13
Q1 2016 34.2M +4.76M +16.2% May 4, 2016 10-Q 2016-05-06
Q4 2015 34.1M +4.66M +15.8% Feb 4, 2016 10-Q 2016-02-09
Q3 2015 29.4M +79.8K +0.27% Sep 4, 2015 10-K 2015-09-10
Q1 2015 29.4M +160K +0.55% May 6, 2015 10-Q 2015-05-08
Q4 2014 29.4M +2.06M +7.52% Feb 3, 2015 10-Q 2015-02-06
Q3 2014 29.3M +2.55M +9.5% Sep 8, 2014 10-K 2014-09-11
Q1 2014 29.3M +5.96M +25.6% May 9, 2014 10-Q 2014-05-14
Q4 2013 27.4M +4.06M +17.4% Feb 7, 2014 10-Q 2014-02-12
Q3 2013 26.8M +3.49M +15% Sep 23, 2013 10-K 2013-09-27
Q1 2013 23.3M +2.49M +12% May 10, 2013 10-Q 2013-05-14
Q4 2012 23.3M +2.49M +12% Feb 6, 2013 10-Q 2013-02-08
Q3 2012 23.3M +2.49M +12% Sep 24, 2012 10-K 2012-09-27
Q1 2012 20.8M May 7, 2012 10-Q 2012-05-10
Q4 2011 20.8M Feb 6, 2012 10-Q 2012-02-09
Q3 2011 20.8M Nov 4, 2011 10-Q/A 2011-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.